Deals
Concordia Healthcare Loses Blackstone, Carlyle Interest
- Private equity firm exits cast doubt on successful sale
- Company’s shares have dropped two-thirds since Amdipharm buy
This article is for subscribers only.
Concordia Healthcare Corp.’s sale process hit a snag after Blackstone Group and Carlyle Group opted not to pursue a takeover for the Canadian drugmaker, according to people familiar with the matter.
The lack of interest from the big private equity firms casts doubt on whether the embattled company will find a buyer, said the people who asked not to be identified as the information is private.